Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines

Liver International

Volumn 29, Issue 9, 2009, Pages 1338-1347

  Wang, Jin ^a   Chan, Judy Yuet Wa ^b   Fong, Chi Chun ^a   Tzang, Chi Hung ^a   Fung, Kwok Pui ^b   Yang, Mengsu ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Doxorubicin; HepG2; Microarray; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER F1; ACTIN RELATED PROTEIN 3; BETA ACTIN; CANCER TESTIS ANTIGEN; CARRIER PROTEIN; CHROMOGRANIN A; COMPLEMENTARY DNA; CYSTEINE AND GLYCINE RICH PROTEIN 1; DOXORUBICIN; EPHRIN A1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP PROTEIN; MELANOMA ANTIGEN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 3; PROTEASOME; PROTEIN P53; SOMATOMEDIN BINDING PROTEIN; SORCIN; TRANSGELIN; TROPOMYOSIN; TUMOR ANTIGEN; UBIQUITIN; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CELL SURVIVAL; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS; TIME; UNINDEXED SEQUENCE; UPREGULATION; DRUG EFFECT; DRUG RESISTANCE; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CLUSTER ANALYSIS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70449702094     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02081.x     Document Type: Article

References (41)

1. D'Arpa P, Liu L.F. Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 1989; 989: 163-7.
2. Lee TK, Lau TC, Ng I.O. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Cancer Chemother Pharmacol 2002; 49: 78-86.
3. Chan JY, Chu AC, Fung K. Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense R.N.A. Life Sci 2000; 67: 2117-24.
4. Pang E, Hu Y, Chan KY, et al. Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells. Lab Invest 2005; 85: 664-74.
5. Kudoh K, Ramanna M, Ravatn R, et al. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 2000; 60: 4161-6.
6. Hoshida Y,Moriyama M, Otsuka M, et al. Gene expressions associated with chemosensitivity in human hepatoma cells. Hepatogastroenterology 2007; 54: 489-92.
7. Moriyama M, Hoshida Y, Otsuka M, et al. Relevance network between chemosensitivity and transcriptome in human hepatoma cells. Mol Cancer Ther 2003; 2: 199-205.
8. Hong Y, Müller UR, Lai F. Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays. Toxicol In Vitro 2003; 17: 85-92.
9. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999; 57: 727-41.
10. Lyu YL, Kerrigan JE, Lin CP, et al. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 2007; 67: 8839-46.
11. Chiao PJ, Na R, Niu J, et al. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 2002; 95: 1696-705.
12. Wong N, YeoW,Wong WL, et al. TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer 2009; 124: 644-52.
13. Perugorria MJ, Castillo J, Latasa MU, et al. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res 2009; 69: 1358-67.
14. Co NN, Tsang WP, Wong TW, et al. Oncogene AF1q enhances doxorubicin-induced apoptosis through BADmediated mitochondrial apoptotic pathway. Mol Cancer Ther 2008; 7: 3160-8.
15. Arai M, Kondoh N, Imazeki N, et al. The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells. Liver Int 2009; 29: 55-62.
16. Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
17. Wang J, Fong CC, Tzang CH, et al. Gene expression analysis of human promyelocytic leukemia HL-60 cell differentiation and cytotoxicity induced by natural and synthetic retinoids. Life Sci 2009; 84: 576-83.
18. Khar A, Li AM, Pardhasaradhi BV, et al. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 2001; 6: 368-76.
19. Beyer-Sehlmeyer G., Hiddemann W, Wormann B, et al. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin. Eur J Cancer 1999; 35: 1735-42.
20. Yamamoto K, Okamoto A, Isonishi S, et al. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance. Cancer Lett 2001; 168: 173-81.
21. Luciani F, Molinari A, Lozupone F, et al. P-glycoproteinactin association through ERM family proteins: a role in Pglycoprotein function in human cells of lymphoid origin. Blood 2002; 99: 641-8.
22. Takeshita H, Kusuzaki K, Ashihara T, et al. Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance. Cancer Lett 1998; 126: 75-81.
23. van der Gaag EJ, Leccia MT, Dekker SK, et al. Role of zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. J Invest Dermatol 2002; 118: 246-54.
24. Oh SH, Adler HJ, Raphael Y, et al. WDR1 colocalizes with ADF and actin in the normal and noise-damaged chick cochlea. J Comp Neurol 2002; 448: 399-409.
25. Ludwig A, Dietel M, Lage H. Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells. Anticancer Res 2002; 22: 3213-21.
26. Leu SJ, Lam SC, Lau L.F. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 2002; 277: 46248-55.
27. Tsai MS, Bogart DF, Castaneda JM, et al. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002; 21: 8178-85.
28. Huang YH,Wu JY, Zhang Y, et al. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Oncogene 2002; 21: 6819-28.
29. Toure A, Dorseuil O, Morin L, et al. MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells. J Biol Chem 1998; 273: 6019-23.
30. Versele M, deWinde JH, Thevelein J.M. A novel regulator of G protein signalling in yeast, Rgs2, downregulates glucoseactivation of the cAMP pathway through direct inhibition of Gpa2. EMBO J 1999; 18: 5577-91.
31. Zmijewski JW, Song L, Harkins L, et al. Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys 2001; 392: 192-6.
32. Carter N, Nakamoto T, Hirai H, et al. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas). Nat Cell Biol 2002; 4: 565-73.
33. Sharfe N, Freywald A, Toro A, et al. Ephrin stimulation modulates T cell chemotaxis. Eur J Immunol 2002; 32: 3745-55.
34. Tourriere H, Chebli K, Zekri L, et al. The RasGAPassociated endoribonuclease G3BP assembles stress granules. J Cell Biol 2003; 160: 823-31.
35. Cheung IY, Cheung NK, Ghossein RA, et al. Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clin Cancer Res 1999; 5: 2042-7.
36. Andrade VC, Vettore AL, Felix RS, et al. Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients. Cancer Immun 2008; 8: 2.
37. Lawson D, Harrison M, Shapland C. Fibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil Cytoskeleton 1997; 38: 250-7.
38. Wang J, Tai L, Tzang CH, et al. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in the acquired vinblastine resistance of human cervical carcinoma KB cells. Oncol Rep 2008; 19: 1155-64.
39. Twentyman P.R. Transport proteins in drug resistance: biology and approaches to circumvention. J Intern. Med 1997; 740(Suppl.): 133-7.
40. Silver S. Genes for all metals - a bacterial view of the periodic table. The 1996 Thom Award Lecture. J Ind Microbiol Biotechnol 1998; 20: 1-12.
41. Bhattacharjee H, Rosen B.P. Structure-function analysis of the ArsA ATPase: contribution of histidine residues. J Bioenerg Biomembr 2001; 33: 459-68.